The mechanistic basis for immune response is thought to occur through a higher proportion of tumor-infiltrating immune cells, increased PD-L1 tumor expression, upregulation of innate and adaptive immune response pathways, and a distinct mutational landscape with increasing TMB10,12. This evidence concerns the gene CD274 and neoplasm.